{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:54:23Z","timestamp":1775912063149,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2013-2603"],"award-info":[{"award-number":["2013-2603"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015736","name":"Folkh\u00e4lsanin Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["21322"],"award-info":[{"award-number":["21322"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["277843"],"award-info":[{"award-number":["277843"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ejmg.2017.09.001","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T21:15:53Z","timestamp":1504905353000},"page":"675-679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["High bone mass due to novel LRP5 and AMER1 mutations"],"prefix":"10.1016","volume":"60","author":[{"given":"Alice","family":"Costantini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e4ivi","family":"Kek\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riikka E.","family":"M\u00e4kitie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Outi","family":"M\u00e4kitie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejmg.2017.09.001_bib1","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/MCB.25.12.4946-4955.2005","article-title":"Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling","volume":"25","author":"Ai","year":"2005","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.ejmg.2017.09.001_bib2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1359\/jbmr.070211","article-title":"Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling","volume":"22","author":"Balemans","year":"2007","journal-title":"J.\u00a0Bone Miner. Res. Offic. J. Am. Soc. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.ejmg.2017.09.001_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.ejmg.2017.09.001_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00223-008-9130-9","article-title":"The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations","volume":"82","author":"Balemans","year":"2008","journal-title":"Calcif. tissue Int."},{"issue":"10","key":"10.1016\/j.ejmg.2017.09.001_bib5","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.str.2011.07.005","article-title":"Wnt antagonists bind through a short peptide to the first beta-propeller domain of LRP5\/6","volume":"19","author":"Bourhis","year":"2011","journal-title":"Structure"},{"issue":"5","key":"10.1016\/j.ejmg.2017.09.001_bib6","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/ajmg.a.35813","article-title":"First evidence of vertical paternal transmission of osteopatia striata with cranial sclerosis","volume":"161","author":"Ciceri","year":"2013","journal-title":"Am. J. Med. Genet. Part A"},{"issue":"4","key":"10.1016\/j.ejmg.2017.09.001_bib7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/ajmg.a.36369","article-title":"A\u00a0novel WTX mutation in a female patient with osteopathia striata with cranial sclerosis and hepatoblastoma","volume":"164A","author":"Fujita","year":"2014","journal-title":"Am. J. Med. Genet. Part A"},{"issue":"4","key":"10.1016\/j.ejmg.2017.09.001_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","article-title":"LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development","volume":"107","author":"Gong","year":"2001","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ejmg.2017.09.001_bib9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/jbmr.2706","article-title":"Mutations in known monogenic high bone mass loci only explain a small proportion of high bone mass cases","volume":"31","author":"Gregson","year":"2016","journal-title":"J.\u00a0Bone Miner. Res. Offic. J. Am. Soc. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.ejmg.2017.09.001_bib10","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1002\/ajmg.a.34178","article-title":"The male phenotype in osteopathia striata congenita with cranial sclerosis","volume":"155","author":"Holman","year":"2011","journal-title":"Am. J. Med. Genet. Part A"},{"issue":"1","key":"10.1016\/j.ejmg.2017.09.001_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ng.270","article-title":"Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis","volume":"41","author":"Jenkins","year":"2009","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.ejmg.2017.09.001_bib12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ejhg.2011.42","article-title":"Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG)","volume":"19","author":"Laine","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"issue":"19","key":"10.1016\/j.ejmg.2017.09.001_bib13","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1215458","article-title":"WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta","volume":"368","author":"Laine","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ejmg.2017.09.001_bib14","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1101\/gr.3437105","article-title":"Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease","volume":"15","author":"Loots","year":"2005","journal-title":"Genome Res."},{"issue":"5827","key":"10.1016\/j.ejmg.2017.09.001_bib15","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science\/1141515","article-title":"Wilms tumor suppressor WTX negatively regulates WNT\/beta-catenin signaling","volume":"316","author":"Major","year":"2007","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ejmg.2017.09.001_bib16","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/jbmr.2841","article-title":"Skeletal characteristics of WNT1 osteoporosis in children and young adults","volume":"31","author":"Makitie","year":"2016","journal-title":"J.\u00a0Bone Miner. Res. Offic. J. Am. Soc. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.ejmg.2017.09.001_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1359\/jbmr.090707","article-title":"Osteopathia striata with cranial sclerosis owing to WTX gene defect","volume":"25","author":"Perdu","year":"2010","journal-title":"J.\u00a0Bone Miner. Res. Offic. J. Am. Soc. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.ejmg.2017.09.001_bib18","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bone.2009.12.022","article-title":"Low-density lipoprotein receptor-related protein 5 (LRP5) variation in fracture prone children","volume":"46","author":"Saarinen","year":"2010","journal-title":"Bone"},{"issue":"22","key":"10.1016\/j.ejmg.2017.09.001_bib19","doi-asserted-by":"crossref","first-page":"19204","DOI":"10.1074\/jbc.M111.224881","article-title":"Structural and functional characterization of the Wnt inhibitor APC membrane recruitment 1 (Amer1)","volume":"286","author":"Tanneberger","year":"2011","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721217303737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721217303737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:45:23Z","timestamp":1761709523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721217303737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1769721217303737"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2017.09.001","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High bone mass due to novel LRP5 and AMER1 mutations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2017.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}